Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid

Background Bempedoic acid (BA) inhibits ATP‐citrate lyase in the cholesterol synthesis pathway and lowers low‐density lipoprotein cholesterol (LDL‐C). As with other lipid‐lowering therapies, interindividual variation in response to BA was observed in clinical trials. We characterized LDL‐C response...

Full description

Bibliographic Details

Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Christie M. Ballantyne, Harold E. Bays, Michael J. Louie, Jeremy Smart, Yang Zhang, Kausik K. Ray
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Subjects:	atherosclerotic cardiovascular disease statin intolerance
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.121.024531